Ly Kawaguchi

Ly Kawaguchi has extensive work experience in the pharmaceutical and biotechnology industry. They are currently the Executive Director at Curis. Prior to this, they worked at MyoKardia as the Senior Director of Development Operations from 2017 to 2021. They also held the position of Director of Clinical Operations at Ultragenyx Pharmaceutical Inc. from 2015 to 2017 and Director of Operations at Allergan from 2011 to 2015. Their earlier experience includes various roles at Genentech, including Manager of Outsourcing from 2006 to 2011, Senior Study Operations Manager from 2000 to 2006, and Research Assistant in BioAnalytical Assay from 1996 to 2000.

Ly Kawaguchi attended the University of California, Davis from 1992 to 1996. During this time, they pursued a Bachelor of Science (B.S.) degree in Environmental Toxicology.